QUICK ANSWER · AEO / GEO
RAD140, vosilasarm and the online term Testolone refer to an investigational SARM candidate; Testolone is not testosterone. A first-in-human study enrolled 22 postmenopausal women with advanced breast cancer and reported target engagement, preliminary antitumour activity and frequent liver-test abnormalities. This does not establish bodybuilding or performance benefit, safety in healthy users or approval. FDA identifies marketed RAD-140 products as unapproved drugs, and WADA prohibits RAD140 at all times.
ENTITY FACTS
What should readers identify first?
What remains unknown?
Insufficient data in the current dataset
What limits these conclusions?
- Oncology target engagement ≠ bodybuilding benefit; Testolone ≠ testosterone; Phase 1 ≠ approval or long-term safety
This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.
EVIDENCE BOUNDARY
What this overview does not establish
- An evidence grade does not rank this molecule against another treatment.
- A molecule name does not establish the identity, purity or regulatory status of a product.
- Animal, cell or biomarker findings do not automatically establish human clinical benefit.
- Approval in one country or indication does not transfer globally.
Where can I check the evidence?
Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.
FAQ · ANSWER ENGINE
Frequently asked questions
What is RAD140 / Vosilasarm?
RAD140 / Vosilasarm is described pharmacologically as Investigational selective androgen receptor modulator. RAD140, vosilasarm and the online term Testolone refer to an investigational SARM candidate; Testolone is not testosterone. A first-in-human study enrolled 22 postmenopausal women with advanced breast cancer and reported target engagement, preliminary antitumour activity and frequent liver-test abnormalities. This does not establish bodybuilding or performance benefit, safety in healthy users or approval. FDA identifies marketed RAD-140 products as unapproved drugs, and WADA prohibits RAD140 at all times.
Does RAD140 / Vosilasarm have strong evidence?
PrimeCoreBio records Evidence Grade C. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.
Is RAD140 / Vosilasarm approved everywhere?
No global conclusion should be inferred. PrimeCore Class B must be read with the exact product, country and indication on the source-rich profile.
Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.